Moreover, the inhibitory effects of ALS-L1023 on triglyceride droplets were reversed by GW6471 in HepG2 cells, suggesting that the actions of ALS-L0123 on hepatic steatosis may be mediated in part through PPARα. The gene discussed is PPARA; the disease is fatty liver disease.